Pfizer’s Paxlovid Likely Relegated To High-Risk COVID-19 Patients

 
• By Alaric DeArment
  
Pfizer announced updated data from the EPIC-SR study • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip